Download
fnagi-13-688478.pdf 1,41MB
WeightNameValue
1000 Titel
  • Validity Evidence for the Research Category, “Cognitively Unimpaired – Declining,” as a Risk Marker for Mild Cognitive Impairment and Alzheimer’s Disease
1000 Autor/in
  1. Langhough Koscik, Rebecca |
  2. Hermann, Bruce P. |
  3. Allison, Samantha |
  4. Clark, Lindsay R. |
  5. Jonaitis, Erin M. |
  6. Mueller, Kimberly D. |
  7. Betthauser, Tobey J. |
  8. Christian, Bradley T. |
  9. Du, Lianlian |
  10. Okonkwo, Ozioma |
  11. Birdsill, Alex |
  12. Chin, Nathaniel |
  13. Gleason, Carey |
  14. Johnson, Sterling C. |
1000 Erscheinungsjahr 2021
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2021-07-26
1000 Erschienen in
1000 Quellenangabe
  • 13:688478
1000 Copyrightjahr
  • 2021
1000 Embargo
  • 2022-01-28
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.3389/fnagi.2021.688478 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8350058/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Abstract/Summary
  • <jats:p>While clinically significant cognitive impairment is the key feature of the symptomatic stages of the Alzheimer’s disease (AD) continuum, subtle cognitive decline is now known to occur years before a clinical diagnosis of mild cognitive impairment (MCI) or dementia due to AD is made. The primary aim of this study was to examine criterion validity evidence for an operational definition of “cognitively unimpaired-declining” (CU-D) in the Wisconsin Registry for Alzheimer’s Prevention (WRAP), a longitudinal cohort study following cognition and risk factors from mid-life and on. Cognitive status was determined for each visit using a consensus review process that incorporated internal norms and published norms; a multi-disciplinary panel reviewed cases first to determine whether MCI or dementia was present, and subsequently whether CU-D was present, The CU-D group differed from CU-stable (CU-S) and MCI on concurrent measures of cognition, demonstrating concurrent validity. Participants who changed from CU-S to CU-D at the next study visit demonstrated greater declines than those who stayed CU-S. In addition, those who were CU-D were more likely to progress to MCI or dementia than those who were CU-S (predictive validity). In a subsample with positron emission tomography (PET) imaging, the CU-D group also differed from the CU-S and MCI/Dementia groups on measures of amyloid and tau burden, indicating that biomarker evidence of AD was elevated in those showing sub-clinical (CU-D) decline. Together, the results corroborate other studies showing that cognitive decline begins long before a dementia diagnosis and indicate that operational criteria can detect subclinical decline that may signal AD or other dementia risk.</jats:p>
1000 Sacherschließung
lokal Alzheimer’s disease
lokal Neuroscience
lokal validity
lokal mild cognitive impairment
lokal transitional cognitive decline
lokal subclinical decline
lokal biomarkers
lokal cognitively unimpaired
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/TGFuZ2hvdWdoIEtvc2NpaywgUmViZWNjYQ==|https://frl.publisso.de/adhoc/uri/SGVybWFubiwgQnJ1Y2UgUC4=|https://frl.publisso.de/adhoc/uri/QWxsaXNvbiwgU2FtYW50aGE=|https://frl.publisso.de/adhoc/uri/Q2xhcmssIExpbmRzYXkgUi4=|https://frl.publisso.de/adhoc/uri/Sm9uYWl0aXMsIEVyaW4gTS4=|https://frl.publisso.de/adhoc/uri/TXVlbGxlciwgS2ltYmVybHkgRC4=|https://frl.publisso.de/adhoc/uri/QmV0dGhhdXNlciwgVG9iZXkgSi4=|https://frl.publisso.de/adhoc/uri/Q2hyaXN0aWFuLCBCcmFkbGV5IFQu|https://frl.publisso.de/adhoc/uri/RHUsIExpYW5saWFu|https://frl.publisso.de/adhoc/uri/T2tvbmt3bywgT3ppb21h|https://frl.publisso.de/adhoc/uri/QmlyZHNpbGwsIEFsZXg=|https://frl.publisso.de/adhoc/uri/Q2hpbiwgTmF0aGFuaWVs|https://frl.publisso.de/adhoc/uri/R2xlYXNvbiwgQ2FyZXk=|https://frl.publisso.de/adhoc/uri/Sm9obnNvbiwgU3RlcmxpbmcgQy4=
1000 Hinweis
  • DeepGreen-ID: 1e801379718341f99e7f7f2e87ef0aa3 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. National Institutes of Health |
  2. Alzheimer's Association |
1000 Fördernummer
  1. -
  2. -
1000 Förderprogramm
  1. -
  2. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer National Institutes of Health |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Alzheimer's Association |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6474754.rdf
1000 Erstellt am 2024-04-11T12:24:25.471+0200
1000 Erstellt von 322
1000 beschreibt frl:6474754
1000 Zuletzt bearbeitet 2024-04-29T11:18:39.154+0200
1000 Objekt bearb. Mon Apr 29 11:18:39 CEST 2024
1000 Vgl. frl:6474754
1000 Oai Id
  1. oai:frl.publisso.de:frl:6474754 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source